HK1074047A1 - Imidazole compounds and their use as ligands of the alpha-" adrenoreceptors - Google Patents

Imidazole compounds and their use as ligands of the alpha-" adrenoreceptors

Info

Publication number
HK1074047A1
HK1074047A1 HK05107889.4A HK05107889A HK1074047A1 HK 1074047 A1 HK1074047 A1 HK 1074047A1 HK 05107889 A HK05107889 A HK 05107889A HK 1074047 A1 HK1074047 A1 HK 1074047A1
Authority
HK
Hong Kong
Prior art keywords
isomers
adrenoreceptors
ligands
alpha
imidazole compounds
Prior art date
Application number
HK05107889.4A
Other languages
English (en)
Inventor
Bernard Vacher
Bernard Bonnaud
Marc Marien
Peter Pauwels
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of HK1074047A1 publication Critical patent/HK1074047A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
HK05107889.4A 2002-05-16 2005-09-08 Imidazole compounds and their use as ligands of the alpha-" adrenoreceptors HK1074047A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0206026A FR2839719B1 (fr) 2002-05-16 2002-05-16 Nouveaux composes imidazoliques, leur procede de preparation et leur utilisation a titre de medicaments
PCT/FR2003/001476 WO2003097611A1 (fr) 2002-05-16 2003-05-15 Composes imidazoliques et leur utilisation en tant que ligands recepterus alpha-2 adrenergiques

Publications (1)

Publication Number Publication Date
HK1074047A1 true HK1074047A1 (en) 2005-10-28

Family

ID=29286544

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05107889.4A HK1074047A1 (en) 2002-05-16 2005-09-08 Imidazole compounds and their use as ligands of the alpha-" adrenoreceptors

Country Status (16)

Country Link
US (2) US7220866B2 (zh)
EP (1) EP1511735B1 (zh)
JP (1) JP4749710B2 (zh)
CN (1) CN100379728C (zh)
AT (1) ATE471932T1 (zh)
AU (1) AU2003255575B2 (zh)
BR (1) BR0311181A (zh)
CA (1) CA2493812C (zh)
DE (1) DE60333095D1 (zh)
ES (1) ES2346136T3 (zh)
FR (1) FR2839719B1 (zh)
HK (1) HK1074047A1 (zh)
MX (1) MXPA04011396A (zh)
PT (1) PT1511735E (zh)
WO (1) WO2003097611A1 (zh)
ZA (1) ZA200409952B (zh)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI81092C (fi) * 1986-05-15 1990-09-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt aktiva 4(5)-(2,3-dihydro-1h-inden-2-yl)-imidazolderivat.
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB9312669D0 (en) * 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
IL152401A0 (en) 2000-05-08 2003-05-29 Orion Corp New polycyclic indanylimidazoles with alpha2 adrenergic activity

Also Published As

Publication number Publication date
US20070197793A1 (en) 2007-08-23
WO2003097611A1 (fr) 2003-11-27
FR2839719B1 (fr) 2004-08-06
JP2005531561A (ja) 2005-10-20
DE60333095D1 (de) 2010-08-05
CA2493812A1 (fr) 2003-11-27
CN1653052A (zh) 2005-08-10
PT1511735E (pt) 2010-08-24
JP4749710B2 (ja) 2011-08-17
EP1511735B1 (fr) 2010-06-23
US20060041001A1 (en) 2006-02-23
US7776901B2 (en) 2010-08-17
BR0311181A (pt) 2005-03-01
EP1511735A1 (fr) 2005-03-09
FR2839719A1 (fr) 2003-11-21
ATE471932T1 (de) 2010-07-15
CA2493812C (fr) 2012-04-03
AU2003255575B2 (en) 2009-03-26
US7220866B2 (en) 2007-05-22
CN100379728C (zh) 2008-04-09
ZA200409952B (en) 2005-09-28
ES2346136T3 (es) 2010-10-11
AU2003255575A1 (en) 2003-12-02
MXPA04011396A (es) 2005-02-14

Similar Documents

Publication Publication Date Title
RS20050311A (en) Selected cgrp antagonists,method for production and use thereof as medicament
NO20062644L (no) DPP-IV inhibitorer
RS20050329A (en) Selected cgrp antagonists,method for production and use thereof as medicament
ATE506354T1 (de) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
WO2005103037A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
WO2005087771A3 (de) 5,6-dialkyl-7-amino-triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
BR0207302A (pt) Trifluorometilpurinas como inibidores da fosfodiesterase 4
MXPA04001685A (es) Derivados de sulfonilamino empleados como herbicida.
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
SE0100902D0 (sv) Compounds
WO2001017972A3 (de) Neue herbizide
MXPA02011370A (es) Iminoazinas substituidas.
RS51200B (sr) (imidazol-1-il-metil)-piridazin kao blokator nmda receptora
HRP20080027T3 (en) 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
RS51146B (sr) Novi difenil-azetidinon sa poboljšanim fiziološkim osobinama postupak za njegovu proizvodnju,lekovi koji sadrže ovo jedinjenje i njihova upotreba
SE0103710D0 (sv) Compounds
RS20050506A (en) Novel herbicides
EA200800149A1 (ru) 4,5-диарилпиррольные производные, способ их получения и применение в терапии
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
WO2005087770A3 (de) 5, 6-dihydrocarbyl-7-amino-triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
HK1074047A1 (en) Imidazole compounds and their use as ligands of the alpha-" adrenoreceptors
DE50311388D1 (de) Nicht-peptidische brs-3-agonisten
WO2007000392A3 (en) Chloro-substituted guanidines
WO2003027060A1 (fr) Derives amide de diphenylbutane

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170515